Qube Research & Technologies (QRT)’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-542,971	Closed	-$19M	–	4980
2024 Q1	$19M	Buy	542,971 +502,472	+1,241%	+$18.3M	0.03%	584
2023 Q4	$1.54M	Buy	+40,499	New	+$868K	﹤0.01%	1674
2023 Q1	–	Sell	-8,207	Closed	-$202K	–	3215
2022 Q4	$202K	Buy	+8,207	New	+$241K	﹤0.01%	1818
2022 Q3	–	Sell	-39,875	Closed	-$453K	–	3295
2022 Q2	$453K	Buy	+39,875	New	+$587K	﹤0.01%	1447

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Qube Research & Technologies (QRT)'s INBX Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 542,971 shares — an estimated $19M sold.

Qube Research & Technologies (QRT) first reported a position in INBX in Q2 2022 and held it in 4 quarters. The position peaked at $19M in Q1 2024. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Qube Research & Technologies (QRT) reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 542,971 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $19M.
Qube Research & Technologies (QRT) first reported a position in Inhibrx, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
Qube Research & Technologies (QRT)'s Inhibrx, Inc. Common Stock position peaked at $19M in Q1 2024.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.